When does the rotigotine patch patent expire?
Rotigotine is sold as a transdermal patch (brand name includes Neupro). The exact “patent expiration” date depends on the country and on which type of legal protection is being referenced (a primary patent, secondary patents, or supplemental exclusivity). Patent terms also differ from marketing exclusivity periods under local drug-regulatory law.
The provided information does not include rotigotine patent or exclusivity dates, so a specific expiration date can’t be stated here.
Which patents matter for rotigotine patches (and why dates differ)?
For drugs like rotigotine patches, companies and courts typically distinguish between:
- Active substance (API) patents covering rotigotine itself.
- Formulation and device patents covering the patch design, materials, or controlled-release aspects.
- Method-of-use patents (specific dosing regimens, indications, or patient subgroups).
Any one of those can expire earlier or later, and follow-on patents can extend market exclusivity until their own expiration.
How do patent expiration and regulatory exclusivity differ?
Even after the last relevant patent expires, regulators can still delay generic or biosimilar entry through exclusivity rules (for example, additional data exclusivity). Conversely, exclusivity might end before every patent has expired if some patents are narrower and not needed for an approval pathway.
Because the question asks only about “patent expiration” and no jurisdiction or patent list is provided, the difference can’t be translated into a single date without external records.
What you can search to get the exact expiration date
To find the correct expiration date for rotigotine patches, you’d normally look up the patents for your target jurisdiction and active product:
- The brand’s patent register or national patent database (country-specific).
- The regulator-linked exclusivity information (country-specific).
- Litigation or patent lists tied to generic entry attempts (often published by the regulator or parties).
If you tell me the country (for example, US, UK, EU, or a specific member state) and the brand (e.g., Neupro), I can pinpoint what to check next and how to interpret the results.
If you share your jurisdiction, I can give a concrete date
What country (or region) are you asking about, and is it Neupro (rotigotine) transdermal patch?